Professor of Pediatrics, University Pennsylvania
Pediatric Gastroenterology
Dr. Robert N. Baldassano, MD
|
|
Give Review
Doctor Robert N. Baldassano, MD is an expert in the field of Pediatric Gastroenterology. He went to medical school at State University of New York Downstate Medical Center College of Medicine. He has 2 awards "Philadelphia Magazine" and "America's Top Doctors". Dr. Robert N. Baldassano is also a published MD. He has 84 paper published. The most recent paper is: O-022Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
Publications
- O-003 Understanding the Relevance of Whole Exome Sequencing Identified Variants in Patients with Very Early-Onset-IBD.
- O-022 Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
- Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota.
- Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans.
- Exome Sequencing Analysis Reveals Variants in Primary Immunodeficiency Genes in Patients With Very Early Onset Inflammatory Bowel Disease.
- Health-Related Quality of Life in Youth with Crohn's Disease: The Role of Disease Activity and Parenting Stress.
- Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases.
- Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease.
- The treatment-naive microbiome in new-onset Crohn's Disease.
- Rectal microRNAs are perturbed in pediatric inflammatory bowel Disease of the colon.
- Changes in Vitamin D-Related Mineral Metabolism Following Induction with Anti-Tumor Necrosis Factor-α Therapy in Crohn's Disease.
- Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's Disease.
- NASPGHAN Single-Topic Symposium: Discovering the Future of Pediatric IBD Care.
- Impact of exome sequencing in inflammatory bowel Disease.
- Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood crohn Disease.
- Targeted resequencing identifies defective variants of decoy receptor 3 in pediatric-onset inflammatory bowel Disease.
- Large Sample Size, Wide Variant Spectrum, and Advanced Machine-Learning Technique Boost Risk Prediction for Inflammatory Bowel Disease.
- A Novel Enteral Nutrition Protocol for the Treatment of Pediatric Crohn's Disease.
- Changes in Vitamin D and Parathyroid Hormone Metabolism in Incident Pediatric Crohn's Disease.
- Treatment Adherence in Adolescents With Inflammatory Bowel Disease: The Collective Impact of Barriers to Adherence and Anxiety/Depressive Symptoms.
- Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel Disease.
- Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPG...
- The contributions of child behavioral functioning and parent distress to family functioning in pediatric inflammatory bowel Disease.
- Meta-analysis identifies 29 additional Ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
- Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel Disease.
- Corrigendum: Meta-analysis identifies 29 additional Ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
- Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel Disease.
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's Disease susceptibility loci.
- Brief report: Barriers to treatment adherence in pediatric inflammatory bowel Disease.
- Determinants of changes in linear growth and body composition in incident pediatric Crohn's Disease.
- Phase I trial of sargramostim in pediatric Crohn's Disease.
- Barriers to oral medication adherence for adolescents with inflammatory bowel Disease.
- Incidence of stricturing and penetrating complications of Crohn's Disease diagnosed in pediatric patients.
- CD68 expression is markedly different in Crohn's Disease and the colitis associated with chronic granulomatous Disease.
- Infliximab therapy in children with concurrent perianal Crohn Disease: observations from REACH.
- Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel Disease.
- Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with Ulcerative colitis.
- Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel Disease.
- Development of extraintestinal manifestations in pediatric patients with inflammatory bowel Disease.
- Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's Disease.
- Inflammatory bowel Disease in African American children compared with other racial/ethnic groups in a multicenter registry.
- Growth hormone treatment for growth failure in pediatric patients with Crohn's Disease.
- Inflammatory bowel Disease: the difference between children and adults.
- Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel Disease.
- Medication adherence and quality of life in pediatric inflammatory bowel Disease.
- Presentation and Disease course in early- compared to later-onset pediatric Crohn's Disease.
- Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel Disease patients six years and younger.
- Prevalence of chronic granulomatous Disease in pediatric patients diagnosed with Crohn's Disease.
- Frequency and clinical correlations of granulomas in children with Crohn Disease.
- Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's Disease and age-related changes in Th1/Th2 cytokine profiles.
- Measuring quality of life in pediatric patients with inflammatory bowel Disease: psychometric and clinical characteristics.
- Gender differences in presentation and course of Disease in pediatric patients with Crohn Disease.
- Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's Disease.
- Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's Disease.
- Immune response to influenza vaccine in pediatric patients with inflammatory bowel Disease.
- Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel Disease patients.
- Risk factors for initial surgery in pediatric patients with Crohn's Disease.
- Predictors of immunomodulator use as early therapy in pediatric Crohn's Disease.
- A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's Disease.
- Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel Disease consortium.
- The bioavailability of oral methotrexate in children with inflammatory bowel Disease.
- Health-related quality of life improves in children and adolescents with inflammatory bowel Disease after attending a camp sponsored by the Crohn's and Colitis Foundat...
- Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn Disease.
- Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's Disease: balance.
- Intestinal interleukin-13 in pediatric inflammatory bowel Disease patients.
- Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel Disease.
- Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?
- Human antichimeric antibody in children and young adults with inflammatory bowel Disease receiving infliximab.
- Infliximab in pediatric Ulcerative colitis: two-year follow-up.
- Inflammatory bowel Disease in early childhood and adolescence: special considerations.
- Safety and steroid-sparing experience using infliximab for Crohn's Disease at a pediatric inflammatory bowel Disease center.
- Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel Disease patients.
- Terminal ileum intubation in pediatric colonoscopy and diagnostic value of conventional small bowel contrast radiography in pediatric inflammatory bowel Disease.
- Inflammatory bowel Disease in children 5 years of age and younger.
- Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn Disease.
- Listeria meningitis after treatment with infliximab.
- Infliximab as a novel therapy for pediatric Ulcerative colitis.
- Total dose intravenous infusion of iron dextran for iron-deficiency Anemia in children with inflammatory bowel disease.
- Biological and novel therapies for inflammatory bowel Disease in children.
- Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel Disease. Report of the North American Society for Pediatric Gastro...
- Transcriptome profiling of human Ulcerative colitis mucosa reveals altered expression of pathways enriched in genetic susceptibility Loci.
- A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel Disease: a case report.
- Are we under- or mistreating patients at the time of presentation?
Schools
SUNY Downstate Medical Center College Of Medicine
Chldns Hospital Of Philadelphia
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
Conditions Treated
- Anemia
- Biliary Atresia
- Crohn's Disease (Regional Enteritis)
- Gastroesophageal Reflux Disease (GERD)
- View All
Doctors Specialties
- Pediatric Gastroenterology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
Education
-
Children's Hospital of Philadelphia -
State University of New York Downstate Medical Center College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Mei-Lun Wang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marianne V. Augustine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice A. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Picoraro, MD |
|
|
Dr. Ritu Verma, MD |
|
|
Dr. Jessica W. Wen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asim Maqbool, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen M. Loomes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin N. Fiorino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Boyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Flick, MD |